CN101874870B - Traditional Chinese medicine for treating chronic hepatitis - Google Patents

Traditional Chinese medicine for treating chronic hepatitis Download PDF

Info

Publication number
CN101874870B
CN101874870B CN2009100832191A CN200910083219A CN101874870B CN 101874870 B CN101874870 B CN 101874870B CN 2009100832191 A CN2009100832191 A CN 2009100832191A CN 200910083219 A CN200910083219 A CN 200910083219A CN 101874870 B CN101874870 B CN 101874870B
Authority
CN
China
Prior art keywords
chinese medicine
parts
traditional chinese
chronic hepatitis
angelica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100832191A
Other languages
Chinese (zh)
Other versions
CN101874870A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wei Dezong
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009100832191A priority Critical patent/CN101874870B/en
Publication of CN101874870A publication Critical patent/CN101874870A/en
Application granted granted Critical
Publication of CN101874870B publication Critical patent/CN101874870B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating chronic hepatitis, and belongs to the field of traditional Chinese medicines for treating the chronic hepatitis. The medicament aims to have good effect and quick response. The traditional Chinese medicine is prepared from raw materials such as virgate wormwood herb, rehmanniae praeparatum, notoginseng root, radix geutianae, Chinese magnoliavine fruit, glossy ganoderma, Chinese angelica, dwarf lilyturf tuber and the like. The traditional Chinese medicine has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis and eliminating dampness and heat, and has the advantages of obvious effect, definite medicinal effect and quick response.

Description

一种治疗慢性肝炎的中药A kind of traditional Chinese medicine for treating chronic hepatitis

技术领域 technical field

本发明属于治疗肝炎的中药领域。The invention belongs to the field of traditional Chinese medicine for treating hepatitis.

背景技术 Background technique

目前的旨在治疗慢性肝炎的中药领域,存在两个方面的不足:一是效果不够明显,二是见效比较迟缓。大批慢性肝炎患者因药物不能有效地缓解肝病特有的严重乏力、肝区隐痛、肝功能下降、肝纤维化严重等问题,患者生存质量下降,患者及其家属对此很不满意。There are two deficiencies in the current field of traditional Chinese medicine aimed at treating chronic hepatitis: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. A large number of patients with chronic hepatitis are unable to effectively relieve severe fatigue, dull pain in the liver area, decreased liver function, and severe liver fibrosis unique to liver disease due to drugs that can not effectively relieve the quality of life of patients. Patients and their families are very dissatisfied with this.

针对以上提出的问题,本发明提供一种治疗慢性肝炎的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a kind of traditional Chinese medicine for treating chronic hepatitis, which can solve the problem that the effect of traditional Chinese medicine treatment is not obvious enough and the effect is relatively slow. It has good effect, quick effect, remarkable effect and exact drug effect. The advantage of quicker results.

发明内容 Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗慢性肝炎的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of chronic hepatitis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

茵陈2——15份      生地3——30份      三七2——12份Yin Chen 2——15 parts Habitat 3——30 parts Sanqi 2——12 parts

龙胆草2——15份    五味子2——15份    灵芝1.5——20份Gentiana 2——15 parts Schisandra 2——15 parts Ganoderma lucidum 1.5——20 parts

当归3——30份      麦冬3——30份Angelica 3 - 30 parts Ophiopogon japonicus 3 - 30 parts

这种治疗慢性肝炎的中药是由下列方法制成的:This traditional Chinese medicine for treating chronic hepatitis is made by the following method:

(1)按上述重量比,将茵陈、生地、龙胆草、五味子、当归、麦冬经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, capillary, raw land, gentian, schisandra, angelica, and Radix Ophiopogon are extracted through a conventional water extraction process to make extract powder;

(2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Panax notoginseng and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。慢性肝炎多是免疫力低下、气滞血瘀所致,故以灵芝、生地扶正培本,益气养血,增强机体免疫力;三七、当归活血化瘀;伍以麦冬、五味子养阴生津,补益肝肾;龙胆草、茵陈清利湿热。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,清利湿热之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. Chronic hepatitis is mostly caused by low immunity and qi stagnation and blood stasis. Therefore, Ganoderma lucidum and Shengdi Fuzheng Peiben are used to nourish qi and blood and enhance the body's immunity; Panax notoginseng and angelica are used to promote blood circulation and remove blood stasis; fifthly, Ophiopogon japonicus and Schisandra are used to nourish yin Producing body fluid, nourishing liver and kidney; All the medicines are compatible and complement each other. They play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, and clearing away dampness and heat. The effect is good, and the effect is fast.

具体实施方式 Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

茵陈30克      生地30克      三七30克Capsicum chen 30g Rehmannia 30g Panax notoginseng 30g

龙胆草30克    五味子30克    灵芝20克Gentiana 30g Schisandra chinensis 30g Ganoderma lucidum 20g

当归30克      麦冬30克Angelica 30 grams Ophiopogon japonicus 30 grams

按规定重量,用常规水提取工艺将茵陈、生地、龙胆草、五味子、当归、麦冬提取,制成浸膏细粉45克,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊339粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract capillary, habitat, gentian, schisandra, angelica, and Ophiopogon japonicus with conventional water extraction technology to make 45 grams of extract powder, grind Sanqi and Ganoderma lucidum into fine powder respectively, and mix with the above extract The cream powder is mixed, stirred evenly, made into fine granules, packed into No. 0 capsules, and made into 339 traditional Chinese medicine capsules, and each capsule contains 0.28 grams of traditional Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (the weight is in grams):

茵陈90克      生地180克     三七80克Capsicum chen 90g Rehmannia 180g Panax notoginseng 80g

龙胆草90克    五味子90克    灵芝120克Gentiana 90g Schisandra 90g Ganoderma lucidum 120g

当归200克     麦冬200克Angelica 200g Ophiopogon japonicus 200g

按上述同样的方法,制成中药胶囊1473粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1473 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

茵陈150克      生地300克      三七120克Capsicum chen 150g Raw ground 300g Panax notoginseng 120g

龙胆草150克    五味子150克    灵芝200克Gentiana 150g Schisandra 150g Ganoderma lucidum 200g

当归300克      麦冬300克Angelica 300g Ophiopogon japonicus 300g

按上述同样的方法,制成中药胶囊2348粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2348 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

茵陈3份    生地5份    三七3份Capsicum chennai 3 parts Rehmannia 5 parts Panax notoginseng 3 parts

龙胆草3份    五味子3份    灵芝3份3 parts gentian 3 parts schisandra 3 parts Ganoderma lucidum

当归5份      麦冬5份Angelica 5 parts Ophiopogon japonicus 5 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

茵陈15份      生地25份      三七10份Capsicum chen 15 parts Raw land 25 parts Panax notoginseng 10 parts

龙胆草15份    五味子10份    灵芝15份Gentiana 15 parts Schisandra 10 parts Ganoderma lucidum 15 parts

当归25份      麦冬25份Angelica 25 parts Ophiopogon japonicus 25 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医慢性肝炎为例,经20例临床观察。选择中医诊断慢性肝炎为标准:肢软乏力,浑身没劲;纳差、腹胀、消化不良;脸色黝黑、有肝面容;肝区隐痛;肝纤维化严重;肝功能转氨酶持续不正常,其它指标如血浆白蛋白、血总胆红素等不合格。如上症状,即可确诊。在确诊观察的对象中,男性9例,女性11例,无其它严重疾病,年龄为51岁-82岁,平均年龄69.7岁。The present invention takes chronic hepatitis of traditional Chinese medicine as an example, through clinical observation of 20 cases. Choose the standard of TCM diagnosis of chronic hepatitis: weak limbs, lack of energy, anorexia, abdominal distension, indigestion; dark complexion, liver face; dull pain in the liver area; severe liver fibrosis; abnormal liver function transaminases, other indicators such as plasma Albumin, total blood bilirubin, etc. were unqualified. The above symptoms can be diagnosed. Among the confirmed observation subjects, there were 9 males and 11 females, without other serious diseases, aged from 51 to 82 years old, with an average age of 69.7 years.

疗效判定:Judgment of curative effect:

1、显效:乏力缓解,身上有劲;纳差、腹胀、肝区隐痛消失,肝区舒适;肝面容有所改观,脸色变得白皙;肝纤维化检查缓解明显;肝功能检查转氨酶接近正常,血浆白蛋白等其它指标有所缓解。1. Significant effect: fatigue relieved, body energetic; anorexia, abdominal distension, and dull pain in the liver area disappeared, and the liver area was comfortable; the face of the liver was improved, and the complexion became fair; Other indicators such as albumin eased.

2、有效:乏力解决,身上有劲,腹胀、纳差、肝面容有所缓解。2. Effective: Fatigue is relieved, body is strong, abdominal distension, anorexia, and liver complexion are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次6粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用3个月后,症状明显改善。临床实验的20人中,显效11人,有效7人,无效2人,总有效率90%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 6 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 3 months of taking, Symptoms improved significantly. Among the 20 people in the clinical trial, 11 showed marked effects, 7 showed effective results, and 2 showed ineffective results. The total effective rate was 90%.

Claims (1)

1.一种治疗慢性肝炎的中药,其特征在于,所述中药是采用中药原料制备,中药原料的重量配比为:1. a kind of Chinese medicine for the treatment of chronic hepatitis, is characterized in that, described Chinese medicine is to adopt Chinese medicine raw material to prepare, and the weight proportion of Chinese medicine raw material is: 茵陈2-15份      生地3-30份      三七2-12份2-15 parts of capillary root 3-30 parts of raw land 2-12 parts of Panax notoginseng 龙胆草2-15份    五味子2-15份    灵芝1.5-20份Gentiana 2-15 parts Schisandra 2-15 parts Ganoderma lucidum 1.5-20 parts 当归3-30份      麦冬3-30份Angelica 3-30 copies Ophiopogon japonicus 3-30 copies 这种治疗慢性肝炎的中药是由下列方法制成的:This traditional Chinese medicine for treating chronic hepatitis is made by the following method: (1)按上述重量比,将茵陈、生地、龙胆草、五味子、当归、麦冬经常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, capillary, raw land, gentian, schisandra, angelica, and Radix Ophiopogon are extracted through a conventional water extraction process to make extract powder; (2)按上述重量比,将三七、灵芝分别研成细粉,与上述浸膏细粉混合,搅拌均匀;制成中药颗粒剂、散剂、胶囊剂、水丸剂、片剂。(2) According to the above weight ratio, grind Sanqi and Ganoderma lucidum into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; make traditional Chinese medicine granules, powders, capsules, water pills, and tablets.
CN2009100832191A 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic hepatitis Expired - Fee Related CN101874870B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100832191A CN101874870B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100832191A CN101874870B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic hepatitis

Publications (2)

Publication Number Publication Date
CN101874870A CN101874870A (en) 2010-11-03
CN101874870B true CN101874870B (en) 2012-07-11

Family

ID=43017616

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100832191A Expired - Fee Related CN101874870B (en) 2009-04-29 2009-04-29 Traditional Chinese medicine for treating chronic hepatitis

Country Status (1)

Country Link
CN (1) CN101874870B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1686529A (en) * 2005-05-20 2005-10-26 李素梅 Ready prepared Chinese medicine for treating diabetes
CN1947777A (en) * 2006-06-18 2007-04-18 芮育健 Method for treating diabets by Fuling, wolfberry fruit and radix scrophulariae with producing saliva and slaking thirst function

Also Published As

Publication number Publication date
CN101874870A (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CN101843694A (en) Chinese medicament for treating chronic hepatitis
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN101530461A (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN101874870B (en) Traditional Chinese medicine for treating chronic hepatitis
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101843877B (en) Chinese medicament for treating liver cirrhosis
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101850020B (en) Chinese medicament for treating chronic kidney failure
CN101843827B (en) Chinese medicament for treating gout
CN102379965A (en) Traditional Chinese medicine for treating chronic prostatitis
CN101843745B (en) Chinese medicament for treating chronic hepatitis
CN101391072B (en) A kind of traditional Chinese medicine for treating diabetic diarrhea
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843703B (en) Chinese medicament for treating liver cirrhosis
CN101843756B (en) Chinese medicament for treating chronic nephritis
CN101843816B (en) Chinese medicament for treating chronic nephritis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101879244A (en) Traditional Chinese medicine for treating cerebral tumors
CN101850054B (en) Chinese medicament for treating diabetic heart diseases
CN101843744B (en) A kind of traditional Chinese medicine for treating chronic renal failure
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843706A (en) Chinese medicament for treating chronic kidney failure
CN101843754A (en) Chinese medicament for treating gout
CN101843817A (en) Chinese medicament for treating chronic hepatitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WEI DEZONG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION

TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui

Patentee after: Wei Dezong

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

DD01 Delivery of document by public notice

Addressee: Wei Dezong

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120711

Termination date: 20180429

CF01 Termination of patent right due to non-payment of annual fee